Jan 3, 2018   SOURCE: PR NewsWire

Valeant To Present At The 36th Annual J.P. Morgan Healthcare Conference

LAVAL, Quebec, Jan. 3, 2018 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") today announced that Joseph C. Papa, chairman and chief executive officer, is scheduled to present at the 36(th) Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, Jan. 10, 2018, at 10:30 a.m. PST (1:30 p.m. EST).

A live webcast and audio archive of the event will be available on the Investor Relations page of the Valeant web site at: http://ir.valeant.com/events-and-presentations/2018.

About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.

    Investor Contact:          Media Contact:

    Arthur Shannon             Lainie Keller

    arthur.shannon@valeant.com lainie.keller@valeant.com

    (514) 856-3855             (908) 927-0617

    (877) 281-6642 (toll free)

View original content with multimedia:http://www.prnewswire.com/news-releases/valeant-to-present-at-the-36th-annual-jp-morgan-healthcare-conference-300574997.html

SOURCE Valeant Pharmaceuticals International, Inc.